Home page Home page
AstraZeneca

Beromun
tasonermin

Package leaflet: Information for the user


Beromun 1 mg powder for solution for infusion

Tasonermin


Read all of this leaflet carefully before you start using this medicine because it contains important information for you.


Common (may affect up to 1 in 10 people)

- infections

- protein in urine


Uncommon (may affect up to 1 in 100 people)

phosphate dodecahydrate and human serum albumin.


What Beromun looks like and contents of the pack

Beromun is a white to off-white powder for solution for infusion (powder for infusion) supplied in a

glass vial with rubber stopper and sealed with aluminium flip-off cap. Each pack contains 4 vials of powder.


Marketing Authorisation Holder

BELPHARMA s.a.

2, Rue Albert 1er

L-1117 Luxembourg

Grand Duchy of Luxembourg


Manufacturer

Eumedica NV

Chemin de Nauwelette 1 B-7170 Manage

Belgium

For any information about this medicine, please contact the Marketing Authorisation Holder:


BELPHARMA s.a.

2, Rue Albert 1er

L-1117 Luxembourg

Grand Duchy of Luxembourg Tel : +352 27403070


This leaflet was last revised in


This leaflet is available in all EU/EEA languages on the European Medicines Agency website.